Harvard Bioscience: Tools to Advance Life Science Research and Regenerative Medicine
 
Click on these icons to download or listen to our latest investor information:  


Investor Relations
 
Investor Presentation
Annual Report
Latest Live Presentation
Earnings Call
Print Page
Email Page
 
Our History Our Mission Financial Performance Business Model
Directions to Harvard Bioscience Investor Contact About Harvard Bioscience

Insider Transactions


Date Name Title Type Shares Traded Price Range
Jun 4, 2010 graziano chane Officer Acquisition (Non Open Market) 133,600 n/a
Jun 4, 2010 Green, David Officer Acquisition (Non Open Market) 133,600 n/a
Jun 4, 2010 luscinski susan m Officer Acquisition (Non Open Market) 66,800 n/a
Jun 4, 2010 mcnaughton thomas Officer Acquisition (Non Open Market) 66,800 n/a
Nov 12, 2009 luscinski susan m Officer Option Execute 98,550 1.05
Sep 16, 2009 Lewis, Earl R. Director Buy 5,534 3.75
Sep 15, 2009 Lewis, Earl R. Director Buy 14,466 3.69 - 3.73
Sep 15, 2009 Uveges, George Director Buy 2,500 3.70
Apr 1, 2009 skystone advisors llc Beneficial Owner (10% or more) Disposition (Non Open Market) 2,746,988 n/a
Mar 26, 2009 skystone advisors llc Beneficial Owner (10% or more) Sell 5,860 3.00
Mar 24, 2009 skystone advisors llc Beneficial Owner (10% or more) Sell 1,300 3.10
Mar 12, 2009 skystone advisors llc Beneficial Owner (10% or more) Sell 7,958 2.75
Mar 5, 2009 Green, David Officer Automatic Buy 453 2.49
Mar 3, 2009 Green, David Officer Automatic Buy 687 2.48 - 2.49
Mar 2, 2009 Green, David Officer Automatic Buy 2,587 2.49
Feb 27, 2009 Green, David Officer Automatic Buy 9,800 2.40 - 2.47
Feb 26, 2009 Green, David Officer Automatic Buy 4,789 2.49
Feb 3, 2009 Green, David Officer Automatic Buy 100 2.49
Feb 2, 2009 Green, David Officer Automatic Buy 722 2.47 - 2.49
Jan 27, 2009 Green, David Officer Automatic Buy 2,100 2.45 - 2.49
Showing 1-20 of 79 transactions Page: 1 2 3 4  See Next 20

Stock transaction information provided by EDGAR Online. Harvard Bioscience, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Disclaimer:
The information contained within this and other Harvard Bioscience Web pages should be deemed accurate and current as of the date of the most recent update, or if no update information has been provided, the date of issuance. Harvard Bioscience assumes no responsibility for any misincurrances or misstatements which occur as the result of the reading of dated material. Users are strongly encouraged to check dates of issuance and most recent update of any information contained within, or linked to, Harvard Bioscience’s web site. For Harvard Bioscience’s most current information please reference Harvard Bioscience public filings with the Securities and Exchange Commission located at http://www.sec.gov.


Privacy Policy   |   Terms and Conditions
Copyright©2010 Harvard Bioscience, Inc. All rights reserved.
1-800-272-2775   1-508-893-8999